Search

Your search keyword '"Lladó, Albert"' showing total 818 results

Search Constraints

Start Over You searched for: Author "Lladó, Albert" Remove constraint Author: "Lladó, Albert"
818 results on '"Lladó, Albert"'

Search Results

2. Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome

3. Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort

5. Early‐onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late‐onset

8. Correction: Cortical microstructure in primary progressive aphasia: a multicenter study

9. Cortical microstructure in primary progressive aphasia: a multicenter study

10. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve.

12. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

13. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

14. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

17. Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia.

18. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy

19. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

22. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

23. Effects of Modified Video-Implemented Script Training for Aphasia in the Three Variants of Primary Progressive Aphasia.

24. Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's disease.

25. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

26. Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort

27. The Cortical Asymmetry Index (CAI) for subtyping dementia patients

28. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease

29. Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity

30. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

31. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

32. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights.

33. Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants

34. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

36. Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort

37. Plasma biomarkers as prognostic markers in Alzheimer’s disease: Influence of age at onset

38. Probabilistic computer‐aided diagnosis of Alzheimer’s disease and frontotemporal dementia based on MRI and biochemical markers

39. Exploring the relationship between MRI changes and cognitive/neuropsychiatric complaints in a cohort of long COVID‐19 patients: A cross‐sectional and longitudinal study

40. Are noradrenergic and orexinergic systems contributing to sleep‐wake patterns in early and late‐onset Alzheimer’s Disease?

41. Cognitive symptoms associated with COVID‐19: neuropsychological and biochemical characterization

43. Plasma Neurofilament Light Chain predicts neuroimaging alterations and functional decline in frontotemporal dementia

44. Diagnostic performance RT‐QuIC based detection of alpha‐synuclein seeds in a clinical cohort with cognitive impairment

45. Comparison of the diagnostic performance of blood‐based biomarkers using two distinct commercially available assays in a prospective memory clinic cohort

46. Catalan Early Onset Dementia Network 2021 Report

47. Digital and plasma biomarkers for an early diagnosis of Mild Cognitive Impairment and prodromal Alzheimer’s disease

48. Diagnosis in an early‐onset dementia clinic in the period 2016‐2021 and impact of COVID‐19 pandemic

49. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

Catalog

Books, media, physical & digital resources